Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Vamsidhar Velcheti, MD, is a staff Physician of Medicine at the Cleveland Clinic Lerner College of Medicine and staff physician in the Department of Hematology and Oncology at Cleveland Clinic Taussig Cancer Institute. His specialty areas include lung cancer, mesothelioma, and thymic tumors and the use of novel immunotherapies for the treatment of lung cancer. Dr.
Lung Cancer Video Library - Gilotrif/ Afatinib in Squamous NSCLC
dbrock
Image
Dr. Vamsidhar Velcheti, Thoracic Oncologist, Hematology and Medical Oncology, Cleveland Clinic, joined GRACE to discuss updates to our Lung Cancer Video Library. In this video, Dr. Velcheti discusses gilotrif/afatanib in squamous non small cell lung cancer.
We would like to thank the following companies for their support of this program
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Online Community
Hi app.92, Welcome to Grace. I'm sorry this is late getting to you. And more sorry your mum is going through this. It's possible this isn't a pancoast tumor even though...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...